Evaluation of efficacy of the fixed vs unfixed combination of latanoprost and timolol in patients of open-angle glaucoma and ocular hypertension insufficiently controlled on timolol and latanoprost monotherapy
Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2017, Vol 7, Issue 8
Abstract
Background: Glaucoma is a term describing a group of ocular disorders with multifactorial etiology united by a clinically characteristic intraocular pressure (IOP) associated optic neuropathy. Elevated IOP is identified as the only known risk factor which can be modified by anti-glaucomatous treatments. Patients who do not achieve target IOP levels with a single ocular hypotensive agent often are prescribed concomitant therapy with a medication that has a different mechanism of action. Aims and Objectives: The aim was to evaluate the efficacy of the fixed and unfixed combinations of latanoprost and timolol in patients of open-angle glaucoma and ocular hypertension (OH). Materials and Methods: A comparative randomized open-label trial was conducted on newly diagnosed patients of open-angle glaucoma and OH who were receiving either latanoprost 0.005% once daily or either timolol SR 0.5% once or twice daily in the preceding 4 weeks and whose IOP was not controlled with the prior monotherapy of latanoprost or timolol and remained ≥21 mmHg were included in the study. Patients were randomized to two groups to receive the following medication - Group I: Fixed combination eye drops of latanoprost (0.005%) and timolol SR (0.5%), once a day, in the dose of 1 drop at 9 LTFC and Group II: Unfixed combination of latanoprost (0.005%), once a day in the dose of 1 drop at 9 pm and timolol SR (0.5%), once a day in the dose of 1 drop at 9 am (LTuFC). Patients were evaluated at 0, 2, 4, 6, and 12 weeks for the assessment of IOP and Visual acuity. Results: Both LTFC (Group I) and LTuFC (Group II) caused a reduction in IOP which was statistically highly significant (P < 0.01) at all the intervals but on comparison both the groups affected the IOP in a similar fashion and demonstrated no difference statistically (P > 0.05). Conclusion: Both the regimens on comparison revealed similar efficacy thereby failing to prove superiority over each other. Thus, the clinicians have a wider choice of fixed or unfixed combinations of latanoprost and timolol, when monotherapy of either drug fails
Authors and Affiliations
Rohini Gupta, Brij Mohan Gupta, Dinesh Gupta, Pavan Malhotra, Zahida Parveen
Drug use pattern of over-the-counter and alternative medications in pregnancy: A cross sectional descriptive study
Background: Drug treatment in pregnancy presents a special concern because of the physiological changes in the mother besides the drug effects on fetus. In addition, usage of drug available over-the-counter (OTC) medic...
Insulin resistance and blood lipid levels during fasting
Background: Fasting is observed by Muslims during Ramzan. Here, they do not consume food and drinks. It is observed for 29–30 days. The fast begins early in the morning and lasts until evening. Aims and Objectives: This...
A comparative study of handgrip strength among sedentary and non-sedentary workers
Background: India is a developing country with a rapid transformation in lifestyle including inappropriate diet and inadequate physical activity. More the physical activity greater will be the muscle strength. Handgrip s...
Night shift working and its impact on sleep quality, calorie intake, and serum thyroid stimulating hormone level among health-care workers in a tertiary hospital, Bengaluru
Background: There are several health and social problems which are associated with shift work. This is mainly due to negative working environment and impairment of biological rhythms during the shift work. Aims and Objec...
Antimicrobial prescribing pattern in urinary tract infection in a tertiary care hospital
Background: Urinary tract infection (UTI) is a common illness affecting both males and females in almost all age groups. Varieties of antimicrobials such as cotrimoxazole, nitrofurantoin, fluoroquinolones, and penicillin...